EPC
Edgewell Personal Care Company17.76
+0.24+1.37%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q1 '26
Phasing details, H2 catalysts clarified
Q&A largely reaffirmed prepared remarks on unchanged FY2026 outlook post-feminine care divestiture, but surfaced granular phasing: international flat in H1 from Japan NPD stock-back and sun distributor timing, accelerating to 6%+ H2; North America to benefit from distribution gains on Cremo and Hawaiian Tropic. Wet shave promo intensity persists, especially women's amid crowded field. Debt reduction prioritizes over M&A; leverage targets 3x end-year. Management dropped 2027 free cash flow marker at $150M+. Confident on H2 share gains. Q&A adds execution details investors track closely.
Key Stats
Market Cap
825.20MP/E (TTM)
33.51Basic EPS (TTM)
0.53Dividend Yield
0.03%Recent Filings
10-Q
Q1 FY2026 results
Edgewell's Q1 FY2026 continuing net sales rose 1.9% y/y to $422.8M, with Wet Shave down 1.1% to $291.3M but Sun and Skin Care up 9.0% to $131.5M; gross margin slipped to 38.1% from 41.6% amid inflation and tariffs. Restructuring charges of $18.1M flipped operating income to a $18.9M loss, while interest drove net loss from continuing ops to $29.2M ($0.63/share, confirmed vs 46.6M diluted shares). Cash held steady at $223.3M, long-term debt at $1,520.8M (5.5%/$750M 2028, 4.1%/$500M 2029, revolver availability $142.5M); operating cash used $125.9M, capex $11.6M. Feminine Care sold Feb 2026 for $340M cash after $37.4M goodwill impairment. Restructuring streamlines supply chain. Raw material costs fluctuate.
8-K
Feminine Care sold for $340M
Edgewell completed its Feminine Care divestiture for $340 million, bolstering the balance sheet while posting Q1 continuing ops net sales of $422.8 million, up 1.9% yet with adjusted EPS at $(0.16). Shareholders approved the 3rd A&R 2018 Stock Plan, adding 2.1 million shares. Full-year continuing ops outlook holds: adjusted EPS $1.70-$2.10. Divestiture sharpens focus.
8-K
Feminine Care sale closes
Edgewell closed the sale of its Feminine Care business to Essity on February 2, 2026, for $340 million cash, subject to post-closing adjustments. Proceeds will repay $140 million revolving debt, strengthening the balance sheet while funding core shave, sun, and skin care growth. Sale simplifies portfolio. Transition services run at least one year.
10-K
FY2025 results
Edgewell Personal Care's FY2025 net sales fell 1.3% to $2.22B organically, with North America down 4.4% on Wet Shave/Feminine Care/Sun Care volume weakness while international grew 3.5%. Wet Shave sales dipped 1.2% organically but profit rose 1.5% organically on margins; Sun/Skin Care edged up 0.9% organically (Grooming/Skin Care gains offsetting Sun declines) yet profit plunged 21.4% organically from higher spending; Feminine Care tumbled 7.7% organically with profit down 43.4%. Q4 momentum faltered amid volume pressures, though Wet Shave held steady. Debt stood at $1.4B (90% fixed-rate, maturities 2028+), revolver availability $279M; $90M buybacks and $0.15/share quarterly dividend continued. Board approved Feminine Care sale for $340M. Walmart drove 17.4% of sales.
8-K
Q4 sales beat, FY dip; FY26 guide
Edgewell Personal Care reported Q4 net sales up 3.8% to $537.2M with 2.5% organic growth, yet full-year sales fell 1.3% to $2.2B amid currency headwinds and North America weakness. Adjusted FY EPS hit $2.52 despite $51.1M Feminine Care goodwill impairment; returned $120M to shareholders. Board approved $100M repurchase authorization. Guides FY26 organic sales flat to +2%, adjusted EPS $2.15-$2.55.
IPO
Website
Employees
Sector
Industry
CHD
Church & Dwight Company, Inc.
84.55-0.46
CL
Colgate-Palmolive Company
78.95-0.48
EL
Estee Lauder Companies, Inc. (T
104.39+3.36
ELF
e.l.f. Beauty, Inc.
78.77+0.17
EWCZ
European Wax Center, Inc.
3.72-0.09
KMB
Kimberly-Clark Corporation
102.54-0.26
NUS
Nu Skin Enterprises, Inc.
10.51+0.01
PG
Procter & Gamble Company (The)
145.21+0.08
SPB
Spectrum Brands Holdings, Inc.
60.20-1.38
UL
Unilever PLC
64.33-0.71